4.8 Editorial Material

A New Role for Cyclic Phosphatidic Acid as a PPARγ Antagonist

Journal

CELL METABOLISM
Volume 12, Issue 3, Pages 207-208

Publisher

CELL PRESS
DOI: 10.1016/j.cmet.2010.08.010

Keywords

-

Ask authors/readers for more resources

A recent study in Molecular Cell (Tsukahara et al., 2010) identifies cyclic phosphatidic acid (CPA) as a naturally occurring PPAR gamma antagonist that can be generated from lysophospholipids by signal-dependent activation of phospholipase D2. This endogenous CPA regulates PPAR gamma functions required for adipogenesis, glucose homeostasis, and vascular wall biology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available